Gene signature may be used to guide therapy for patients with ER-positive breast cancer.
The FDA has approved Zydelig for relapsed chronic lymphocytic leukemia, follicular B-cell non-Hodgkin lymphoma, and small lymphocytic lymphoma.
Experts note study findings aren't definitive, and risk is minimal.
Findings based on aqueous-gel form of lanreotide treatment versus placebo.
Poor concordance regarding prognosis and goals of care; variation seen by cancer type.
Renal tumors occur at a frequency 7.5 times greater in lithium-treated patients than in the general population, French study shows.
Renal function is preserved better compared with radical nephrectomy even when tumors are larger than the traditional 4 cm cutoff.
In advanced cancer patients receiving opioids, methylprednisolone does not add to analgesic effect.
There's no way to guarantee that laparoscopic power morcellation won't increase the risk of spreading cancer.
Two different studies found that rates of observation for low-risk prostate cancer vary widely, and ADT is not linked to improved survival.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|